Investigating Intratumoral Modulation Therapy as a Novel Treatment Modality for Brain Metastases
Investigating Intratumoral Modulation Therapy as a Novel Treatment Modality for Brain Metastases
研究瘤内调制疗法作为脑转移瘤的新型治疗方式
批准号：
449409
负责人：
Uzelac Mila
金额：
$1.27万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
中文摘要
翻译
脑转移瘤，也被称为继发性脑肿瘤，最常见于肺癌和乳腺癌，发病率是原发性脑肿瘤的10倍，发生在10%至30%的癌症患者中。中位生存期为3至6个月
英文摘要
Brain metastases, also known as secondary brain tumours, most commonly arise from lung and breast cancer and are 10 times more common than primary brain tumours, occurring in 10 to 30 percent of cancer patients. With the median survival being 3 to 6 month
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
